Melanoma-associated antigen 3 (MAGE-A3), a CTA highly expressed in NSCLC 11, 12, is intracellularly processed with human leukocyte antigens (HLAs) on the cell surface, therefore, was utilized as an important therapeutic target in NSCLC. The gene discussed is MAGEA3; the disease is non-small cell lung carcinoma.